Dyna Levetiracetam 250 mg, 500 mg, 750 mg FC tablet.
PDF Leaflet Revision Date: 11 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Monotherapy and adjunctive therapy for epilepsy.
Dosage (summary)
Starting at 250 mg twice daily, max 1500 mg twice daily for monotherapy; 500 mg twice daily for adjunctive therapy, max 3000 mg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Methotrexate
- Probenecid
- Other antiepileptics
Contraindications
- Hypersensitivity to levetiracetam
- Pregnancy
- Lactation
Common side effects
- Somnolence
- Headache
- Dizziness
- Fatigue
- Nasopharyngitis
Counselling Points
- Take with or without food
- Do not double dose if missed
- Monitor for mood changes
Serious warnings
- Risk of suicidal thoughts and behavior
- Monitor for psychiatric symptoms
Important Disclaimer
The Dyna Levetiracetam 250 mg, 500 mg, 750 mg FC tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
